PE-Backed Life Sciences Tools Platform Development

Financial Services
Projects / Diligences Completed for the Platform
Cumulative Number of Stakeholder Interviews
Life Science Market Segments / Applications Characterized / Modelled for Prioritization
Project Details
Voice-of-Customer Research
Customer Segmentation
Pricing Strategy
Due Diligence
Competitive Analysis
Revenue Projection


A leading private equity firm and management team sought out DeciBio as a strategic partner to advise on the life sciences market and perform due-diligences in support of the development of a novel life sciences tools platform

Our Approach

Secondary Research

  • Performed a market landscape assessment to identify high-growth, high-margin segments within the life sciences research tools market in which to invest
  • Reviewed and pressure-tested company memoranda and financial documents of multiple potential targets against market benchmarks and competitors
  • Analyzed hundreds of publications and clinical trials to assess the relative utilization and applications of various research tools 

‍Primary Research

  • Identified and interviewed >100 customers in academia, diagnostics, and biopharma industries to gauge awareness, utilization, and perception of target companies, their products, and their competitors
  • Assessed market and segment drivers, moderators, and trends, and how these impacted the competitiveness of the target companies
  • Elucidated the distinct value proposition and positioning of target companies within their markets

Quantitative Analysis

  • Developed custom market models to forecast the size and growth of key market segments
  • Developed detailed near-mid and long-term revenue and market share forecasts for key targets
  • Evaluated various market and competitive scenarios that could impact target company revenues and profitability


Key takeaways from DeciBio’s work included:

  • Recommendations on the attractiveness of various potential acquisition targets, resulting in multiple successful acquisitions for the platform, as well as foregone deals 
  • The establishment of an ongoing, dynamic relationship in which DeciBio serves as a trusted and invested strategic partner in the platform

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch